Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green
- PMID: 1768562
- PMCID: PMC1368549
Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green
Abstract
1. The applicability of a continuous infusion of indocyanine green (ICG) to detect changes in apparent hepatic blood flow (HBF) was investigated in six healthy subjects. 2. High-performance liquid chromatography was used to measure ICG concentrations, and the effect of intravenous propranolol (10 mg in 10 min) on HBF was investigated. 3. During 150 min infusions of ICG (1.0 mg min-1) steady-state was reached within about 30 min and thereafter the plasma dye concentration remained essentially constant until the end of infusion. 4. Blood clearance (CLb) of ICG (15.9 +/- 2.2 ml min-1 kg-1; mean +/- s.d.), calculated as infusion rate/blood dye concentration over three time periods (30-50, 80-100 and 130-150 min) during the 150 min infusion, was not different from that obtained with three 1-min infusions (0.5 mg kg-1) administered at corresponding times of the day (CLb = 14.0 +/- 2.2 ml min-1 kg-1, P = 0.06). 5. The pharmacokinetics of ICG were shown to be linear up to plasma concentrations of at least 3 micrograms ml-1 using variable infusion rates (0.5, 1.0 and 2.0 mg min-1). 6. Propranolol had little effect on ICG concentrations during continuous infusion. The AUC of ICG from the start of propranolol infusion up to 125 min thereafter was increased by 12% +/- 17% (P = 0.21) compared with placebo.
Similar articles
-
Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.Hepatology. 1993 Dec;18(6):1504-15. Hepatology. 1993. PMID: 8244277
-
Determination of hepatic blood flow in the rat using sequential infusions of indocyanine green or galactose.Drug Metab Dispos. 1990 Mar-Apr;18(2):197-202. Drug Metab Dispos. 1990. PMID: 1971573
-
Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model.Br J Surg. 2000 May;87(5):568-74. doi: 10.1046/j.1365-2168.2000.01399.x. Br J Surg. 2000. PMID: 10792311
-
Indocyanine green kinetics characterize blood volume and flow distribution and their alteration by propranolol.Clin Pharmacol Ther. 2000 Apr;67(4):342-50. doi: 10.1067/mcp.2000.104945. Clin Pharmacol Ther. 2000. PMID: 10801242 Clinical Trial.
-
Effects of propofol and dexmedetomidine on indocyanine green elimination assessed with LIMON to patients with early septic shock: a pilot study.J Crit Care. 2009 Dec;24(4):603-8. doi: 10.1016/j.jcrc.2008.10.005. J Crit Care. 2009. PMID: 19931154
Cited by
-
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.Eur J Clin Pharmacol. 2008 Dec;64(12):1147-61. doi: 10.1007/s00228-008-0553-z. Epub 2008 Sep 2. Eur J Clin Pharmacol. 2008. PMID: 18762933 Review.
-
Design and conduct considerations for studies in patients with hepatic impairment.Clin Transl Sci. 2023 Jan;16(1):50-61. doi: 10.1111/cts.13428. Epub 2022 Oct 9. Clin Transl Sci. 2023. PMID: 36176049 Free PMC article. Review.
-
Assessment of liver metabolic function. Clinical implications.Clin Pharmacokinet. 1994 Sep;27(3):216-48. doi: 10.2165/00003088-199427030-00005. Clin Pharmacokinet. 1994. PMID: 7988103 Review.
-
Dose adjustment in patients with liver disease.Drug Saf. 2005;28(6):529-45. doi: 10.2165/00002018-200528060-00005. Drug Saf. 2005. PMID: 15924505 Review.
-
Prediction of Survival After Partial Hepatectomy Using a Physiologically Based Pharmacokinetic Model of Indocyanine Green Liver Function Tests.Front Physiol. 2021 Nov 22;12:730418. doi: 10.3389/fphys.2021.730418. eCollection 2021. Front Physiol. 2021. PMID: 34880771 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous